John Zhong

1.4k total citations
12 papers, 1.1k citations indexed

About

John Zhong is a scholar working on Infectious Diseases, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, John Zhong has authored 12 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in John Zhong's work include Bacillus and Francisella bacterial research (3 papers), Multiple Sclerosis Research Studies (3 papers) and Systemic Lupus Erythematosus Research (3 papers). John Zhong is often cited by papers focused on Bacillus and Francisella bacterial research (3 papers), Multiple Sclerosis Research Studies (3 papers) and Systemic Lupus Erythematosus Research (3 papers). John Zhong collaborates with scholars based in United States, Netherlands and Italy. John Zhong's co-authors include William W. Freimuth, Winn Chatham, W. Joseph McCune, William Stohl, Marc Chévrier, Michelle Petri, Wendy Cai, Arthur Weinstein, G. Mani Subramanian and Gabriel Meister and has published in prestigious journals such as New England Journal of Medicine, Hepatology and Clinical Infectious Diseases.

In The Last Decade

John Zhong

12 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John Zhong United States 10 574 499 433 262 116 12 1.1k
J. S. Hill Gaston United Kingdom 20 834 1.5× 520 1.0× 99 0.2× 200 0.8× 72 0.6× 40 1.4k
Tilman Gerlach Germany 19 689 1.2× 250 0.5× 144 0.3× 138 0.5× 185 1.6× 25 2.4k
Shogo Ohkoshi Japan 15 209 0.4× 231 0.5× 366 0.8× 376 1.4× 154 1.3× 45 2.2k
F Celada Italy 16 626 1.1× 138 0.3× 427 1.0× 302 1.2× 82 0.7× 37 1.1k
Gerlinde Obermoser Austria 19 930 1.6× 367 0.7× 148 0.3× 213 0.8× 185 1.6× 30 1.6k
Kyoichi Kano United States 22 856 1.5× 119 0.2× 301 0.7× 409 1.6× 69 0.6× 119 1.8k
H. Dunckley Australia 21 729 1.3× 301 0.6× 115 0.3× 102 0.4× 42 0.4× 73 1.2k
Winfried Schraut Germany 18 1.2k 2.1× 216 0.4× 160 0.4× 303 1.2× 236 2.0× 20 2.9k
Siegfried Goerg Germany 9 1.1k 1.9× 168 0.3× 211 0.5× 98 0.4× 91 0.8× 15 1.4k
Noriyoshi Kuzushita Japan 21 521 0.9× 127 0.3× 88 0.2× 200 0.8× 74 0.6× 36 1.3k

Countries citing papers authored by John Zhong

Since Specialization
Citations

This map shows the geographic impact of John Zhong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Zhong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Zhong more than expected).

Fields of papers citing papers by John Zhong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Zhong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Zhong. The network helps show where John Zhong may publish in the future.

Co-authorship network of co-authors of John Zhong

This figure shows the co-authorship network connecting the top 25 collaborators of John Zhong. A scholar is included among the top collaborators of John Zhong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Zhong. John Zhong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Sabeti, Mohammad, et al.. (2021). Valacyclovir in Pain Management of Acute Apical Abscesses: A Randomized Placebo-Controlled Double-Blind Pilot Study. Journal of Endodontics. 47(11). 1724–1728. 9 indexed citations
2.
Gasperini, Claudio, Raymond Hupperts, Jan Lycke, et al.. (2016). Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29. Journal of the Neurological Sciences. 370. 123–131. 10 indexed citations
3.
Mehta, Lahar, Manjit McNeill, Jeremy Hobart, et al.. (2015). Identifying an important change estimate for the Multiple Sclerosis Walking Scale-12 (MSWS-12v1) for interpreting clinical trial results. Multiple Sclerosis Journal - Experimental Translational and Clinical. 1. 2450016961–2450016961. 43 indexed citations
4.
McNeill, Liz, et al.. (2014). Quality of Life Among Patients with Multiple Sclerosis Treated with Prolonged-Release Fampridine 10 Mg Tablets for Walking Impairment. Value in Health. 17(7). A401–A402. 1 indexed citations
5.
Migone, Thi‐Sau, Sally D. Bolmer, John Zhong, et al.. (2014). Added Benefit of Raxibacumab to Antibiotic Treatment of Inhalational Anthrax. Antimicrobial Agents and Chemotherapy. 59(2). 1145–1151. 32 indexed citations
6.
Migone, Thi-Sau, G. Mani Subramanian, John Zhong, et al.. (2009). Raxibacumab for the Treatment of Inhalational Anthrax. New England Journal of Medicine. 361(2). 135–144. 202 indexed citations
7.
Lalezari, Jacob, Gopal Yadavalli, Michael F. Para, et al.. (2008). Safety, Pharmacokinetics, and Antiviral Activity of HGS004, a Novel Fully Human IgG4 Monoclonal Antibody against CCR5, in HIV‐1–Infected Patients. The Journal of Infectious Diseases. 197(5). 721–727. 58 indexed citations
8.
Furie, Richard, William Stohl, Ellen M. Ginzler, et al.. (2008). Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus. Arthritis Research & Therapy. 10(5). R109–R109. 205 indexed citations
9.
Petri, Michelle, William Stohl, Winn Chatham, et al.. (2008). Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus. Arthritis & Rheumatism. 58(8). 2453–2459. 329 indexed citations
10.
Halpern, Wendy, Patrick B. Lappin, Thomas A. Zanardi, et al.. (2006). Chronic Administration of Belimumab, a BLyS Antagonist, Decreases Tissue and Peripheral Blood B-Lymphocyte Populations in Cynomolgus Monkeys: Pharmacokinetic, Pharmacodynamic, and Toxicologic Effects. Toxicological Sciences. 91(2). 586–599. 113 indexed citations
11.
Subramanian, G. Mani, et al.. (2005). A Phase 1 Study of PAmAb, a Fully Human Monoclonal Antibody against Bacillus anthracis Protective Antigen, in Healthy Volunteers. Clinical Infectious Diseases. 41(1). 12–20. 75 indexed citations
12.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. S. Hill Gaston Breakdown of academic impact, for papers by Tilman Gerlach Breakdown of academic impact, for papers by Shogo Ohkoshi Breakdown of academic impact, for papers by F Celada Breakdown of academic impact, for papers by Gerlinde Obermoser Breakdown of academic impact, for papers by Kyoichi Kano Breakdown of academic impact, for papers by H. Dunckley Breakdown of academic impact, for papers by Winfried Schraut Breakdown of academic impact, for papers by Siegfried Goerg Breakdown of academic impact, for papers by Noriyoshi Kuzushita
Rankless by CCL
2026